CD8A and neoplasm: Flow cytometric analysis at an interim timepoint (17 days after tumor inoculation) and study endpoint (25 days after tumor inoculation) confirmed depletion of CD3+CD8+ T cells in the spleens and tumors of CD8α-treated mice compared to IgG2B isotope-treated control (Figures 4B-E).